Market Overview:
The worldwide autoinjectors market has been projected to generate a worth of USD 79,741 million by 2024. The market is likely to grow at a CAGR of 17.42% over the forecast period.
An autoinjector is a medical equipment that is mostly used in delivering doses of certain drugs. The autoinjectors are syringes that come with spring loaded within it. These devices are simple to use and handle. Hence, autoinjectors have become widely popular among unskilled or untrained individuals. Autoinjectors are generally used for self-administration purposes. There has been a prevailing anxiety regarding self-administration with the application of needle-based devices. Therefore, autoinjectors came as an answer to such anxieties. The self-administration cure market shows tremendous growth potential particularly in the needle-free injectors and pen injectors segments, consequently impacting the autoinjector market positively.
The autoinjector technology has evolved largely in the recent times. The device comprises a pre-filled cartridge or syringe placed inside an equipment that puts sufficient force to inject fully the needed drug as per the required dosage.
Access Full Report Details and Full TOC Exclusively @ https://www.marketresearchfuture.com/reports/autoinjectors-market-6311
Key Players:
• Amgen Inc
• Dickinson and Company
• Ypsomed
• Teva Pharmaceutical Industries Ltd
• SHL Group
• Owen Mumford Ltd
• Consort Medical
• Eli Lilly and Company
• Antares Pharma
• Johnson & Johnson Services Inc
Market Segmentation:
The global autoinjectors market has been segmented based on the design therapeutic application, product type, region, and distribution channel.
Based on product type, the global autoinjectors market has been segmented into reusable autoinjectors and disposable autoinjectors. Disposable autoinjectors segment held a major market share during 2018. The segment has been anticipated to dominate the market and record a significant CAGR to attain USD 53,696.20 million by the conclusion of 2024. Growing demand for new drug testing, chemical testing, biopharmaceutical, and pharmaceutical drives the disposable autoinjectors segment to a large extent. Moreover, the disposable autoinjectors segment is likely to witness the highest CAGR of 17.90% over 2019 to 2024.
Regional Analysis:
In 2018, the Americas registered the highest market share of 40.6%, and the regional market has been anticipated to record a CAGR of 16.60% over the forecast period. By 2024, the European market has been anticipated to exceed USD 24,307.74 million by 2024. The technological progress, novelty in drug delivery framework, rising prevalence of anaphylaxis incidences, well-established healthcare infrastructure, cancer, and diabetes are the aspects affecting the rapid expansion of the global autoinjectors market in the area. Germany has been a key contributor to the development of the local market, trailed by France. The Asia-Pacific market has been likely to list the swiftest CAGR. The Indian market has been anticipated to reflect the largest growth rate of 18.95% over the forecast period of 2019 to 2024.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]